Literature DB >> 20209343

Chagas' disease and ageing: the coexistence of other chronic diseases with Chagas' disease in elderly patients.

Rosalía Matera de Angelis Alves1, Raquel Prado Thomaz, Eros Antônio de Almeida, Jamiro da Silva Wanderley, Maria Elena Guariento.   

Abstract

This study aimed to identify the main comorbidities in elderly chagasic patients treated in a reference service and identify possible associations between the clinical form of Chagas' disease and chronic diseases. Ninety patients aged 60 years-old or over were interviewed and their clinical diagnoses recorded. The study population profile was: women (55.6%); median age (67 years); married (51.1%); retired (73.3%); up to four years' education (64.4%); and earning less than two minimum wages (67.8%). The predominant forms of Chagas' disease were the cardiac (46.7%) and mixed forms (30%). There was a greater proportion of mild cardiac dysfunction (84.1%), frequently in association with megaesophagus. The mean number of concurrent diseases was 2.856 +/- 1.845, and 33% of the patients had four or more comorbidities. The most frequent were systemic arterial hypertension (56.7%), osteoporosis (23.3%), osteoarthritis (21.2%) and dyslipidemia (20%). Positive correlations were verified between sex and comorbidities and between age group and comorbidities.

Entities:  

Mesh:

Year:  2009        PMID: 20209343     DOI: 10.1590/s0037-86822009000600002

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  17 in total

1.  The enigmatic role of cholinergic reflex in the pathogenesis of Chagas disease.

Authors:  Luiz G F de A B D'Elia Zanella; Agnaldo Bruno Chies; Maria Angélica Spadella; Altino Luiz Silva Therezo; Patrícia de Souza Rossignoli; Fernando Frei; Luciamáre Perinetti Alves Martins
Journal:  Parasitol Res       Date:  2014-04-01       Impact factor: 2.289

2.  The detection of Trypanosoma cruzi by nested-PCR in elderly patients: relationship to the clinical and epidemiological profile.

Authors:  Mariane Barroso Pereira; Angélica Martins Batista; Camila Aguiar; Glaucia Elisete Barbosa Marcon; Luiz Cláudio Martins; Maria Elena Guariento; Sandra Cecília Botelho Costa; Eros Antonio de Almeida
Journal:  Pathog Glob Health       Date:  2016-09-26       Impact factor: 2.894

3.  New Scheme of Intermittent Benznidazole Administration in Patients Chronically Infected with Trypanosoma cruzi: Clinical, Parasitological, and Serological Assessment after Three Years of Follow-Up.

Authors:  María Gabriela Álvarez; Juan Carlos Ramírez; Graciela Bertocchi; Marisa Fernández; Yolanda Hernández; Bruno Lococo; Constanza Lopez-Albizu; Alejandro Schijman; Carolina Cura; Marcelo Abril; Susana Laucella; Rick L Tarleton; María Ailen Natale; Melisa Castro Eiro; Sergio Sosa-Estani; Rodolfo Viotti
Journal:  Antimicrob Agents Chemother       Date:  2020-08-20       Impact factor: 5.191

4.  Epidemiology of mortality related to Chagas' disease in Brazil, 1999-2007.

Authors:  Francisco Rogerlândio Martins-Melo; Carlos Henrique Alencar; Alberto Novaes Ramos; Jorg Heukelbach
Journal:  PLoS Negl Trop Dis       Date:  2012-02-14

5.  Clinical and epidemiological profile of elderly patients with Chagas disease followed between 2005-2013 by pharmaceutical care service in Ceará State, Northeastern Brazil.

Authors:  Laíse dos Santos Pereira; Erlane Chaves Freitas; Arduína Sofia Ortet de Barros Vasconcelos Fidalgo; Mônica Coelho Andrade; Darlan da Silva Cândido; José Damião da Silva Filho; Vladimir Michailowsky; Maria de Fátima Oliveira; José Ajax Nogueira Queiroz
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2015 Mar-Apr       Impact factor: 1.846

6.  Mortality Trends for Neglected Tropical Diseases in the State of Sergipe, Brazil, 1980-2013.

Authors:  Marcos Antônio Costa de Albuquerque; Danielle Menezes Dias; Lucas Teixeira Vieira; Carlos Anselmo Lima; Angela Maria da Silva
Journal:  Infect Dis Poverty       Date:  2017-02-08       Impact factor: 4.520

7.  Neglected tropical diseases in Brazilian children and adolescents: data analysis from 2009 to 2013.

Authors:  Eduardo Brandão; Sebastián Romero; Maria Almerice Lopes da Silva; Fred Luciano Neves Santos
Journal:  Infect Dis Poverty       Date:  2017-11-03       Impact factor: 4.520

8.  Factors associated with quality of life in patients with Chagas disease: SaMi-Trop project.

Authors:  Nayara Dornela Quintino; Ester Cerdeira Sabino; José Luiz Padilha da Silva; Antonio Luiz Pinho Ribeiro; Ariela Mota Ferreira; Gabriela Lemes Davi; Claudia Di Lorenzo Oliveira; Clareci Silva Cardoso
Journal:  PLoS Negl Trop Dis       Date:  2020-05-27

9.  A protocol update for the Selenium Treatment and Chagasic Cardiomyopathy (STCC) trial.

Authors:  Marcelo Teixeira Holanda; Mauro Felippe Felix Mediano; Alejandro Marcel Hasslocher-Moreno; Sérgio Salles Xavier; Roberto Magalhães Saraiva; Andrea Silvestre Sousa; Erica Rodrigues Maciel; Fernanda Martins Carneiro; Paula Simplicio da Silva; Luiz Henrique Conde Sangenis; Henrique Horta Veloso; Claudia Santos de Aguiar Cardoso; Maria da Gloria Bonecini-Almeida; Andreia Lamoglia Souza; Eric Henrique Roma; Marcos José Azevedo; Fernanda Sant'Ana Pereira-Silva; Luis Otavio Pimentel; Marcelo Oliveira Mendes; Luciana Ribeiro Garzoni; Beatriz M S Gonzaga; Anna Cristina Calçada Carvalho; Pedro Emmanuel Alvarenga Americano Brasil; Gilberto Marcelo Sperandio da Silva; Tania Cremonini Araújo-Jorge
Journal:  Trials       Date:  2018-09-19       Impact factor: 2.279

10.  Immunothrombotic dysregulation in chagas disease and COVID-19: a comparative study of anticoagulation.

Authors:  Laura Pérez-Campos Mayoral; María Teresa Hernández-Huerta; Dulce Papy-García; Denis Barritault; Edgar Zenteno; Luis Manuel Sánchez Navarro; Eduardo Pérez-Campos Mayoral; Carlos Alberto Matias Cervantes; Margarito Martínez Cruz; Gabriel Mayoral Andrade; Malaquías López Cervantes; Gabriela Vázquez Martínez; Claudia López Sánchez; Socorro Pina Canseco; Ruth Martínez Cruz; Eduardo Pérez-Campos
Journal:  Mol Cell Biochem       Date:  2021-06-10       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.